chr2-159325680-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_013450.4(BAZ2B):āc.6182A>Gā(p.Asp2061Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000377 in 1,591,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_013450.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BAZ2B | NM_013450.4 | c.6182A>G | p.Asp2061Gly | missense_variant | 35/37 | ENST00000392783.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BAZ2B | ENST00000392783.7 | c.6182A>G | p.Asp2061Gly | missense_variant | 35/37 | 5 | NM_013450.4 | P1 | |
BAZ2B | ENST00000392782.5 | c.6074A>G | p.Asp2025Gly | missense_variant | 34/36 | 1 | |||
BAZ2B | ENST00000548440.1 | n.696A>G | non_coding_transcript_exon_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000351 AC: 8AN: 227726Hom.: 0 AF XY: 0.0000242 AC XY: 3AN XY: 123852
GnomAD4 exome AF: 0.00000347 AC: 5AN: 1439806Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 715694
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74326
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.6182A>G (p.D2061G) alteration is located in exon 35 (coding exon 33) of the BAZ2B gene. This alteration results from a A to G substitution at nucleotide position 6182, causing the aspartic acid (D) at amino acid position 2061 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at